5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.28▲ | 3.29▲ | 3.31▲ | 3.33▼ | 3.61▼ |
MA10 | 3.27▲ | 3.29▲ | 3.21▲ | 3.60▼ | 3.75▼ |
MA20 | 3.28▲ | 3.18▲ | 3.21▲ | 3.68▼ | 4.65▼ |
MA50 | 3.16▲ | 3.35▼ | 3.53▼ | 3.85▼ | 6.43▼ |
MA100 | 3.21▲ | 3.68▼ | 3.76▼ | 4.89▼ | N/A |
MA200 | 3.57▼ | 3.58▼ | 3.67▼ | 6.18▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | 0.033▲ | 0.046▲ | -0.042▼ | 0.011▲ |
RSI | 64.658▲ | 54.557▲ | 50.451▲ | 43.540▼ | 36.681▼ |
STOCH | 66.071 | 76.517 | 88.353▲ | 20.052 | 29.961 |
WILL %R | 0.000▲ | -10.843▲ | -10.843▲ | -66.438 | -81.250▼ |
CCI | 173.833▲ | 69.959 | 89.241 | -91.509 | -100.499▼ |
Thursday, June 12, 2025 05:00 AM
BOSTON & MONTREAL, June 12, 2025--enGene Holdings Inc. (Nasdaq: ENGN, or "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced its financial results for ...
|
Monday, June 09, 2025 05:00 PM
BOSTON & MONTREAL, June 04, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, announced today that Dr. Raj Pruthi ...
|
Monday, June 09, 2025 02:05 PM
ENGENE HOLDINGS ($ENGN) is expected to release its quarterly earnings data on Wednesday, June 11th after market close, per Finnhub. Analysts are expecting revenue of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 3.28 | 3.44 | 3.22 | 3.33 | 48,040 |
12/06/25 | 3.36 | 3.37 | 2.90 | 3.25 | 187,315 |
11/06/25 | 3.38 | 3.38 | 3.05 | 3.22 | 201,970 |
10/06/25 | 3.37 | 3.37 | 3.02 | 3.30 | 114,868 |
09/06/25 | 3.7601 | 3.8742 | 3.5582 | 3.5582 | 218 |
06/06/25 | 3.6812 | 3.8378 | 3.6618 | 3.7558 | 464 |
05/06/25 | 3.7723 | 3.799 | 3.6868 | 3.6868 | 205 |
04/06/25 | 4.1561 | 4.1812 | 3.7783 | 3.7783 | 513 |
03/06/25 | 3.9296 | 4.1574 | 3.919 | 4.1495 | 227 |
02/06/25 | 3.7293 | 4.0047 | 3.6959 | 3.9351 | 162 |
|
|
||||
|
|
||||
|
|